Wegovy Cost Calculator 2026
Wegovy pill from $149/month. Injectable from $199 through NovoCare. Find out what you'll actually pay.
Injectable list price $1,640/month. Pill list price $299/month. Savings card: $25/month.
Estimate Your Monthly Cost
⚠️ Indicated for obesity/weight loss — Novo Nordisk
2026 GLP-1 Drug Pricing Comparison
| Drug | List Price | With Insurance | Savings Card | For |
|---|---|---|---|---|
Wegovy semaglutide | $1,640 | ~$25–50 | $25/mo | obesity |
Ozempic semaglutide | $1,029 | ~$25–50 | $25/mo | type 2 diabetes |
Mounjaro tirzepatide | $1,069 | ~$25–50 | $25/mo | type 2 diabetes |
Zepbound tirzepatide | $1,059 | ~$25–50 | $25/mo | obesity |
Saxenda liraglutide | $1,349 | ~$100–50 | $100/mo | obesity |
Rybelsus semaglutide (oral) | $998 | ~$10–50 | $10/mo | type 2 diabetes |
Wegovy Pills (oral semaglutide) semaglutide (oral) | $299 | ~$25–50 | $25/mo | obesity |
Prices as of 2026. Actual copays depend on your specific plan. Savings card eligibility varies.
How Much Does Wegovy Cost in 2026?
Wegovy pricing in 2026 has a meaningful new variable: the pill. Novo Nordisk launched oral semaglutide (Wegovy in pill form) in early 2026, giving patients a needle-free option at a dramatically lower list price. Here's the full picture of what Wegovy actually costs in 2026 across all payment scenarios.
Wegovy Pill vs. Injectable — Price Comparison
| Option | List Price | NovoCare Cash-Pay | Savings Card |
|---|---|---|---|
| Wegovy Injectable (2.4mg) | $1,640/mo | $349/mo | $25/mo |
| Wegovy Pill (oral, 14mg) | $299/mo | $149/mo | $25/mo |
Wegovy Injectable Pricing
Wegovy injectable (semaglutide subcutaneous injection) remains the primary form with the longest clinical track record. Its $1,640/month list price is among the highest of any GLP-1, but very few patients pay this amount. With commercial insurance that covers GLP-1s for weight loss, copays after the savings card run $25/month. Through NovoCare Pharmacy (Novo Nordisk's direct program), self-pay patients pay $199–$349/month depending on their dose titration phase.
Wegovy Pill — The 2026 Game-Changer
The Wegovy pill (oral semaglutide 3mg, 7mg, 14mg) launched in 2026 as a major accessibility improvement. The pill must be taken on an empty stomach 30 minutes before food or liquid with up to 4 oz of plain water. Clinical trials showed comparable weight loss outcomes to the injectable at equivalent doses for many patients. Through NovoCare Pharmacy, the pill starts at $149/month for self-pay patients — making Wegovy meaningfully more accessible than ever without insurance.
With Commercial Insurance
Commercial insurance coverage for Wegovy is patchy. Employer plans that specifically include anti-obesity medication (AOM) benefits cover Wegovy, often at $25–$100/month copay after prior authorization. Plans without AOM coverage require you to pay out-of-pocket. The Novo Nordisk savings card reduces commercially insured patients' costs to $25/month, but is not usable with Medicare, Medicaid, or government plans.
Prior authorization for Wegovy typically requires a BMI of 30+ (or 27+ with at least one weight-related condition like hypertension or sleep apnea), plus documentation of previous attempts at lifestyle intervention. Your doctor handles the PA process — allow 2–4 weeks for approval.
Medicare and Wegovy in 2026
Medicare does not cover Wegovy for weight loss as of 2026. This affects millions of seniors who could benefit from the medication. Some Medicare Advantage (Part C) plans have begun adding supplemental AOM coverage — check your plan's Evidence of Coverage. If you have Type 2 diabetes and want semaglutide covered by Medicare, Ozempic is the appropriate medication.
Wegovy vs. Ozempic — Cost Comparison
Both Wegovy and Ozempic contain semaglutide, but they differ in dose, indication, and cost:
- List price: Wegovy $1,640/mo vs. Ozempic $1,029/mo — Ozempic is cheaper
- Insurance coverage: Ozempic covered broadly for T2D; Wegovy coverage depends on your employer's AOM policy
- Medicare: Ozempic covered for T2D; Wegovy not covered for weight loss
- Dose: Wegovy tops out at 2.4mg/week; Ozempic at 1.0mg/week — Wegovy delivers higher doses for greater weight loss
- Cash-pay: Both available through NovoCare; Ozempic $349/mo, Wegovy injectable $349/mo, Wegovy pill $149/mo
Frequently Asked Questions
How much does Wegovy cost per month in 2026?
Wegovy injectable has a list price of $1,640/month in 2026. The new Wegovy Pill (oral semaglutide) lists at $299/month. With the Novo Nordisk savings card, commercially insured patients pay as low as $25/month. Through NovoCare Pharmacy (self-pay), the injectable costs $199–$349/month depending on dosage phase. Without any savings programs, list price applies.
What is the Wegovy pill and how much does it cost?
Novo Nordisk launched Wegovy in pill form (oral semaglutide) in 2026 as a needle-free alternative for weight management. The pill comes in 3mg, 7mg, and 14mg doses with a list price of $299/month. Through NovoCare Pharmacy, self-pay patients can get the Wegovy pill starting at $149/month. The pill requires taking it 30 minutes before eating or drinking with plain water.
Does insurance cover Wegovy?
Insurance coverage for Wegovy is much more limited than for Ozempic. Because Wegovy is FDA-approved for obesity/weight loss (not diabetes), many commercial plans exclude it or require step therapy. Employer plans with anti-obesity medication (AOM) coverage do cover Wegovy — copays are typically $25–$100/month. Medicare does NOT cover Wegovy for weight loss. Medicaid coverage varies by state and has been cut in several states in 2025–2026.
What is the difference between Wegovy and Ozempic cost?
Both contain the same active ingredient (semaglutide), but Wegovy carries a higher list price ($1,640 vs $1,029/month) and has significantly worse insurance coverage because it is approved for obesity rather than diabetes. Ozempic at $349/month through NovoCare and broad Medicare coverage makes it cheaper for uninsured and Medicare patients. Wegovy is indicated for weight loss at higher doses (up to 2.4mg vs 1.0mg for Ozempic).
Will Medicare cover Wegovy in 2026?
Medicare does not currently cover Wegovy for weight loss as of April 2026. The Treat and Reduce Obesity Act (TROA), if passed, would expand Medicare Part D to cover anti-obesity medications including Wegovy. Some Medicare Advantage plans have added supplemental AOM coverage — check your plan's evidence of coverage document. If you have Type 2 diabetes, Ozempic (same active ingredient) IS covered by Medicare.
Compare other GLP-1 medications: